Screening for Prostate Cancer | Zendy

David C. Grossman | Zendy; Susan J. Curry | Zendy; Douglas K Owens | Zendy; Kirsten BibbinsDomingo | Zendy; Aaron B. Caughey | Zendy; Karina W. Davidson | Zendy; Chyke A. Doubeni | Zendy; Mark H. Ebell | Zendy; John W. Epling | Zendy; Alex R. Kemper | Zendy; Alex H. Krist | Zendy; Martha Kubik | Zendy; C. Seth Landefeld | Zendy; Carol M. Mangione | Zendy; Michael Silverstein | Zendy; Melissa A. Simon | Zendy; Albert L. Siu | Zendy; ChienWen Tseng | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Screening for Prostate Cancer

Author(s) -

David C. Grossman,

Susan J. Curry,

Douglas K Owens,

Kirsten BibbinsDomingo,

Aaron B. Caughey,

Karina W. Davidson,

Chyke A. Doubeni,

Mark H. Ebell,

John W. Epling,

Alex R. Kemper,

Alex H. Krist,

Martha Kubik,

C. Seth Landefeld,

Carol M. Mangione,

Michael Silverstein,

Melissa A. Simon,

Albert L. Siu,

ChienWen Tseng

Publication year - 2018

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2018.3710

Subject(s) - overdiagnosis , medicine , prostate cancer , prostate cancer screening , cancer , prostate , gynecology , prostate specific antigen , oncology , family history

In the United States, the lifetime risk of being diagnosed with prostate cancer is approximately 13%, and the lifetime risk of dying of prostate cancer is 2.5%. The median age of death from prostate cancer is 80 years. Many men with prostate cancer never experience symptoms and, without screening, would never know they have the disease. African American men and men with a family history of prostate cancer have an increased risk of prostate cancer compared with other men.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research